Overview
Megan Huchko, MD, MPH, holds a dual appointment as an Associate Professor in the Department of Obstetrics & Gynecology and the Duke Global Health Institute. Dr. Huchko was an undergraduate at Duke before moving to New York City to complete medical school at the Albert Einstein College of Medicine, and residency training at Columbia Presbyterian Medical Center. She completed her fellowship in Reproductive Infectious Disease the University of California, San Francisco, and was a faculty member there.
Dr. Huchko practices as an ob/gyn generalist and specializes in cervical cancer prevention through her clinical work and global women’s health research. Her research focuses on optimizing the diagnosis and treatment of cervical cancer among vulnerable women in settings where health disparities occur. She has been working with the Family AIDS Care and Education Services (FACES) program in the Nyanza Province of western Kenya since 2006.
She designed and implemented a cervical cancer screening and prevention (CCSP) program for HIV-infected women enrolled in care at FACES. The CCSP program has provided a clinical resource, as well as a cohort to evaluate the epidemiology of cervical cancer among HIV-infected women, the feasibility of integrating cervical cancer prevention programs into HIV and general outpatient clinics, the safety of various diagnostic and treatment modalities, the efficacy of low-cost/low-resource screening modalities in HIV-infected women and provider and patient-level barriers and facilitators to uptake of cervical cancer prevention activities.
Currently, she is carrying out several large studies in central Uganda and western Kenya to evaluate the optimal implementation strategy for HPV-based cervical cancer screening in rural settings. At Duke, she leads the Center of Excellence in Global Women’s Health through the Global Health Institute and serves as Director for the Ob/Gyn Clinical Research Unit (CRU).
Current Appointments & Affiliations
Recent Publications
Automated Image Clarity Detection for the Improvement of Colposcopy Imaging with Multiple Devices.
Journal Article Biomed Signal Process Control · February 2025 UNLABELLED: The proportion of women dying from cervical cancer in middle- and low-income countries is over 60%, twice that of their high-income counterparts. A primary screening strategy to eliminate this burden is cervix visualization and application of 3 ... Full text Link to item CiteUpdated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Journal Article J Low Genit Tract Dis · January 13, 2025 OBJECTIVE: The purpose of this review was to examine new evidence since our 2019 guidelines for cervical cancer (CC) screening in non-HIV immunocompromised persons and to provide updated recommendations based on literature review and expert opinion. In add ... Full text Link to item CitePrimary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
Journal Article AIDS · December 1, 2024 OBJECTIVE: To compare the model-predicted benefits, harms, and cost-effectiveness of cytology, cotesting, and primary HPV screening in US women with HIV (WWH). DESIGN: We adapted a previously published Markov decision model to simulate a cohort of US WWH. ... Full text Link to item CiteRecent Grants
mSaada: a mobile application to strengthen community-based cervical cancer screening
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027Technology-enabled Single-Visit Model for Cervical Cancer Prevention at the Community Level
ResearchCo-Principal Investigator · Awarded by National Cancer Institute · 2022 - 2027Developing a Stigma-Responsive Intervention to Offer Cervical Cancer Prevention Services in HIV Care Facilities
ResearchPrincipal Investigator · Awarded by Fogarty International Center · 2022 - 2025View All Grants